IP wars: F&P Healthcare hit with mirror lawsuit
F&P accuses ResMed of stealing ideas, its rival does the same – and tries to stop export and sale of F&P's products.
Calida Smylie
Thu, 18 Aug 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Two days after Fisher & Paykel Healthcare [NZX:FPH ] filed patent infringement proceedings against New York stock exchange-listed ResMed [NYSE:RMD] , the rival has turned around and accused F&P of the same thing.
On Tuesday, F&P filed proceedings in the US District Court for the Central District of
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Subscribe Now
Monthly Premium Online Subscription
NZ$49.95 / monthly
Subscribe Now
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Subscribe Now
Yearly Premium Online Subscription
NZ$499.00 / yearly
Subscribe Now
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly
credit card debit
Subscribe Now
Premium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly
credit card debit
Subscribe Now
Yearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Subscribe Now
Individual
Group membership
NBR Marketplace
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
Calida Smylie
Thu, 18 Aug 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.